NRG GY017: Anti PD-L1 (Atezolizumab) as an Immune Primer and Concurrently with Extended Field Chemoradiotherapy for Node Positive Locally Advanced Cervical Cancer

This Study is
No Longer Enrolling

Details
Age

Adult

Phase

I - Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants.

Type of Study

Treatment

Locations

Lone Tree Medical Center
University of Colorado Hospital

Study ID

Protocol Number: 19-1151

More information available at ClinicalTrials.gov: NCT03738228

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers